Metric Finance
LearnFAQ
LearnFAQ

Learn / VERA

NASDAQ: VERA

Vera Therapeutics (VERA) stock, explained like you're 5

Vera Therapeutics trades on the Nasdaq under the ticker VERA. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.2 billion dollars.

Ticker
VERA
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Mid cap, about 2.2 billion dollars

Is Vera Therapeutics a small, medium or large cap company?

No. Vera Therapeutics is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.2 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Vera Therapeutics makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves VERA stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Vera Therapeutics Stock In Focus As Kidney Trial Results Head To ASN Conference (Simply Wall Street)
  • NVDA Stock Rises Premarket: Vera Rubin AI Accelerator Delivers 2X Profit Per GW Than Blackwell, Semianalysis Says (Stocktwits)
  • Vera Bradley: Despite 140% Rally, The Stock Is Still Undervalued (Seeking Alpha)
  • Fast paced Momentum Stock Vera Bradley (VRA) Is Still Trading at a Bargain (Yahoo Finance)
  • Verastem Oncology Announces Pricing of $250 Million Offering of Common Stock and Pre Funded Warrants (Business Wire)

Follow VERA in your daily brief

Each trading day at 5 PM ET we post what happened to Vera Therapeutics and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow VERA

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Vera Therapeutics stock

What does Vera Therapeutics do?

Vera Therapeutics trades on the Nasdaq under the ticker VERA. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.2 billion dollars.

What is the ticker symbol for Vera Therapeutics?

Vera Therapeutics trades under the ticker VERA on the Nasdaq.

What is Vera Therapeutics's market cap?

Vera Therapeutics is a mid cap stock with a market cap of about 2.2 billion dollars.

How does Vera Therapeutics make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves VERA stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow VERA stock every day?

Add VERA to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow VERA daily

A free brief on Vera Therapeutics and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare VERA: VERA vs NVS, VERA vs AZN, VERA vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed